Pragmatic use of insulin degludec/insulin aspart co-formulation: A multinational consensus statement

Autor: Sanjay Kalra, Zafar A Latif, Abdurrahman Comlekci, Guillermo Gonzalez Galvez, Rached Malik, Md Faruque Pathan, Ajay Kumar

Publikováno v: Indian Journal of Endocrinology and Metabolism, Vol 20, Iss 4, Pp 542-545 (2016)

Insulin degludec/insulin aspart (IDegAsp) is a modern coformulation of ultra-long-acting basal insulin degludec, with rapid-acting insulin aspart. IDegAsp provides effective, safe, well-tolerated glycemic control, with a low risk of hypoglycemia whil

Externí odkaz: https://doaj.org/article/ba9f14ce55af4b4eb0fab7062ec19338

Effectiveness and Safety of Initiation and Titration of Insulin Glargine 300 U/mL in Insulin-Naive Patients with Type 2 Diabetes Mellitus Uncontrolled on Oral Antidiabetic Drug Treatment in Turkey: The EASE Study

Autor: Berrin Çetinarslan, Şevki Çetinkalp, Ahmet Kaya, Canan Ersoy, Nur Kebapçı, Abdurrahman Çömlekçi, Neslihan Başçıl Tütüncü, Oğuzhan Deyneli, Aytekin Oğuz, Hasan İlkova, Temel Yılmaz, Zeliha Hekimsoy, Mustafa Ünübol, Mustafa Kemal Balcı, Ayşegül Atmaca, Selçuk Dağdelen, İlhan Yetkin, Serdar Güler, Göktürk Ötünç, Leyla Özhan

Publikováno v: Endocrinology Research and Practice, Vol 28, Iss 1, Pp 4-11 (2024)

Externí odkaz: https://doaj.org/article/52958bbb4466429d85c014be5f42244b

Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial

Autor: Pankaj Joshi, Michael A. Nauck, Mansoor Husain, Mette Thomsen, Abdurrahman Comlekci, Ofri Mosenzon, Denise R. Franco, Kathleen Dungan, Wayne Huey-Herng Sheu, Mette Strange, Jeppe Gram, Nikhil Tandon, Stephen C. Bain, Maria C. Faingold, Cees J. Tack, Cristian Guja, Ole K. Jeppesen, Chaicharn Deerochanawong, Robert Silver, Agostino Consoli, Michael E. Farkouh, Rosario Arechavaleta, Sue D. Pedersen, Paweł Bogdański, Rachid Malek, Juan F. Merino-Torres

Publikováno v: Diabetes, Obesity & Metabolism
Bain, S C, Mosenzon, O, Arechavaleta, R, Bogdański, P, Comlekci, A, Consoli, A, Deerochanawong, C, Dungan, K, Faingold, M C, Farkouh, M E, Franco, D R, Gram, J, Guja, C, Joshi, P, Malek, R, Merino-Torres, J F, Nauck, M A, Pedersen, S D, Sheu, W H H, Silver, R J, Tack, C J, Tandon, N, Jeppesen, O K, Strange, M, Thomsen, M & Husain, M 2019, ' Cardiovascular safety of oral semaglutide in patients with type 2 diabetes : Rationale, design and patient baseline characteristics for the PIONEER 6 trial ', Diabetes, Obesity and Metabolism, vol. 21, no. 3, pp. 499-508 . https://doi.org/10.1111/dom.13553
Diabetes, Obesity & Metabolism, 21, 499-508
DIABETES OBESITY & METABOLISM
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Diabetes, Obesity & Metabolism, 21, 3, pp. 499-508

Aims: To assess the cardiovascular (CV) safety of oral semaglutide, the first tablet formulation of a glucagon-like peptide-1 receptor agonist. Materials and methods: PIONEER 6 is a multinational, randomized, placebo-controlled, double-blind trial in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54341ae6292c251c8c3acbf8d25f23d5
https://doi.org/10.1111/dom.13553

Automation, Evaluation The Laboratory Performance And Clinical Usefullness Of A Low Cost Fructosamine Assay

Autor: Firat Bayraktar, Abdurrahman Comlekci, Banu Önvural, Canan Çoker, Funda Doğruak, Tuncay Küme

Publikováno v: Volume: 33, Issue: 1 9-17
Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi

INTRODUCTION: The aim of this study was to optimise and automate a low cost fructosamine assay and then to investigate the relationship between serum fructosamine levels and long-term complications. METHODS: Serum fructosamine and HbA1c were measured

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb605a82392eee7f6e6710707edfef73
https://avesis.deu.edu.tr/publication/details/8102c96b-5db6-4c85-bf69-00113cd9384f/oai

Follicular Variant of Papillary Thyroid Carcinoma Arising in a Mature Cystic Teratoma of the Ovary

Autor: Meral Koyuncuoglu, Ali Cenk Özay, Berrin Acar, Abdurrahman Comlekci, Özlen Emekçi Özay

Publikováno v: Journal of Gynecological Research and Obstetrics. 2:078-080

Mature cystic teratomas form approximately 20% of all ovarian tumours. Of these, approximately 15% include benign thyroid tissue

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a3149f8e84b193d3e68a770153a84372
https://doi.org/10.17352/jgro.000026